Caelyx indgives intravenøst i en dosis på 50 mg/ m2 én gang hver fjerde uge, så længe sygdommen ikke progredierer, og patienten fortsætter med at tolerere behandlingen.
Caelyx is administered intravenously at a dose of 50 mg/ m2 once every 4 weeks for as long as the disease does not progress and the patient continues to tolerate treatment.